Advertisement
Singapore markets close in 22 minutes
  • Straits Times Index

    3,286.68
    -6.45 (-0.20%)
     
  • Nikkei

    37,628.48
    -831.60 (-2.16%)
     
  • Hang Seng

    17,284.54
    +83.27 (+0.48%)
     
  • FTSE 100

    8,094.22
    +53.84 (+0.67%)
     
  • Bitcoin USD

    63,888.88
    -2,823.65 (-4.23%)
     
  • CMC Crypto 200

    1,365.63
    -16.94 (-1.23%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • Dow

    38,460.92
    -42.77 (-0.11%)
     
  • Nasdaq

    15,712.75
    +16.11 (+0.10%)
     
  • Gold

    2,337.40
    -1.00 (-0.04%)
     
  • Crude Oil

    83.22
    +0.41 (+0.50%)
     
  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     
  • FTSE Bursa Malaysia

    1,570.51
    -0.97 (-0.06%)
     
  • Jakarta Composite Index

    7,154.34
    -20.20 (-0.28%)
     
  • PSE Index

    6,574.88
    +2.13 (+0.03%)
     

BRIEF-Jiangsu Hengrui Medicine in licensing agreement with Japan's Oncolys Biopharma

Dec 2 (Reuters) - Jiangsu Hengrui Medicine Co Ltd * Says it signs licensing agreement with Japan's Oncolys Biopharma on medicine telomelysin's sales in China, Hong Kong and Macau Source text in Chinese: http://bit.ly/2gPt1wc Further company coverage: (Reporting by Hong Kong newsroom)